Rigel Pharmaceuticals (RIGL) Gross Profit Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.94% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 16.94% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,488.21% |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | 10.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.81% |
| Dec 31, 2025 | 23.24% |
| Sep 30, 2025 | 36.86% |
| Jun 30, 2025 | 185.54% |
| Mar 31, 2025 | 77.85% |
| Dec 31, 2024 | 61.89% |
| Sep 30, 2024 | 75.99% |
| Jun 30, 2024 | 31.86% |
| Mar 31, 2024 | 9.63% |
| Dec 31, 2023 | -37.17% |
| Sep 30, 2023 | 21.24% |
| Jun 30, 2023 | -10.33% |
| Mar 31, 2023 | 51.04% |
| Dec 31, 2022 | 155.68% |
| Sep 30, 2022 | 3.59% |
| Jun 30, 2022 | 10.12% |
| Mar 31, 2022 | -79.41% |
| Dec 31, 2021 | 9.89% |
| Sep 30, 2021 | 17.22% |
| Jun 30, 2021 | 66.03% |
| Mar 31, 2021 | 45.13% |
| Dec 31, 2020 | 19.10% |
| Sep 30, 2020 | -11.18% |
| Jun 30, 2020 | 55.92% |
| Mar 31, 2020 | 344.24% |
| Dec 31, 2019 | -59.59% |
| Sep 30, 2019 | 328.42% |
| Jun 30, 2019 | 474.62% |